Pegylated
Showing 1401 - 1416 of 1,416
Age-Related Macular Degeneration Trial (pegaptanib sodium (Macugen))
Completed
- Age-Related Macular Degeneration
- pegaptanib sodium (Macugen)
- (no location specified)
May 2, 2006
Diabetic Macular Edema Trial (pegaptanib sodium (Macugen))
Completed
- Diabetic Macular Edema
- pegaptanib sodium (Macugen)
- (no location specified)
May 2, 2006
Chronic Hepatitis C, Chronic Hepatitis B Trial in San Antonio (4-Methylumbelliferone (Heparvit®))
Unknown status
- Chronic Hepatitis C
- Chronic Hepatitis B
- 4-Methylumbelliferone (Heparvit®)
-
San Antonio, TexasUniversity Health Center Downtown "Brady/Green", 527 North Leona
Sep 7, 2006
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B
Completed
- Coinfection With Hepatitis B Virus and Hepatitis C Virus
- Monoinfection With Hepatitis C Virus
-
Taipei city, Taiwan, ChinaPei-Jer Chen
Aug 4, 2006
Chronic Hepatitis C, HCV Genotype 1 Trial in University College London Hospital (Pegylated interferon-alfa2a (Pegasys);
Completed
- Chronic Hepatitis C, HCV Genotype 1
- Pegylated interferon-alfa2a (Pegasys); ribavirin
-
University College London Hospital, London, United KingdomHepatitis Clinic
Nov 29, 2005
HIV Trial in Clamart (Interferon alfa-2b, Structured treatment interruptions)
Terminated
- HIV Infections
- Interferon alfa-2b
- Structured treatment interruptions
-
Clamart, FranceService de Medecine Interne
Aug 15, 2005
Chronic Hepatitis C Trial in Grenoble (therapeutic drug monitoring of ribavirin and dose adaptation)
Terminated
- Chronic Hepatitis C
- therapeutic drug monitoring of ribavirin and dose adaptation
-
Grenoble, Franceuniversity hospital ; HGE dpt
Sep 13, 2005
Chronic Hepatitis B Trial (interferon alpha 2b plus ribavirin, interferon alpha 2b plus )
Completed
- Chronic Hepatitis B
- interferon alpha 2b plus ribavirin
- interferon alpha 2b plus placebo
- (no location specified)
Jan 11, 2006
Patients With Chronic HCV Infection by Genetic Profile
Unknown status
- Hepatitis C Virus Chronic Infection
-
Jerusalem, IsraelHadassah Medical Organization
Jan 4, 2006
Macular Degeneration, Choroidal Neovascularization Trial in Baltimore (EYE001 anti-VEGF aptamer)
Completed
- Macular Degeneration
- Choroidal Neovascularization
- EYE001 anti-VEGF aptamer
-
Baltimore, MarylandFoundation for Fighting Blindness
Jun 23, 2005
Neurocognitive Functioning in Hepatitis C Pre- and
Unknown status
- Hepatitis C
- Hepatitis B
-
Toronto, Ontario, CanadaLiver Clinic, Toronto Western Hospital, UHN.
Nov 28, 2005
Hepatitis C, Hepatitis B Trial in Toronto (Pegasys; Copegus.)
Unknown status
- Hepatitis C
- Hepatitis B
- Pegasys; Copegus.
-
Toronto, Ontario, CanadaLiver Clinic, Toronto Western Hospital, UHN.
Nov 28, 2005
Aggressive Non-Hodgkin's Lymphoma in the Elderly. Trial in Worldwide (Cyclophosphamide, oncovin, myocet, prednisone & rituximab
Unknown status
- Aggressive Non-Hodgkin's Lymphoma in the Elderly.
- Cyclophosphamide, oncovin, myocet, prednisone & rituximab (R-COMP)
-
Paris, France
- +4 more
Oct 26, 2005
Hepatitis C, Chronic Trial (Amantadine sulphate (in addition to standard treatment))
Unknown status
- Hepatitis C, Chronic
- Amantadine sulphate (in addition to standard treatment)
- (no location specified)
Aug 24, 2005
Hepatitis C, Chronic Trial in Lyon Cedex (peg-interferon alfa-2b, ribavirin, amantadine)
Terminated
- Hepatitis C, Chronic
- peg-interferon alfa-2b
- +2 more
-
Lyon Cedex, FranceService d'Hépato-Gastroentérologie Hopital Hotel Dieu
Jul 28, 2005